Cargando…

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet

OBJECTIVE: Reducing FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) can be clinically beneficial in IBS but the mechanism is incompletely understood. We aimed to detect microbial signatures that might predict response to the low FODMAP diet and assess whether micro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vervier, Kevin, Moss, Stephen, Kumar, Nitin, Adoum, Anne, Barne, Meg, Browne, Hilary, Kaser, Arthur, Kiely, Christopher J, Neville, B Anne, Powell, Nina, Raine, Tim, Stares, Mark D, Zhu, Ana, De La Revilla Negro, Juan, Lawley, Trevor D, Parkes, Miles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Irritable Bowel Syndrome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380505/ https://www.ncbi.nlm.nih.gov/pubmed/34810234 http://dx.doi.org/10.1136/gutjnl-2021-325177

Ejemplares similares

Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
por: Yan, Ran, et al.
Publicado: (2020)

A Swedish national adoption study of risk of irritable bowel syndrome (IBS)
por: Waehrens, Rasmus, et al.
Publicado: (2017)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
por: Atarodi, Sima, et al.
Publicado: (2015)

Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trial
por: Ali, Ather, et al.
Publicado: (2017)

Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial
por: Tazzyman, Simon, et al.
Publicado: (2015)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Gut microbiome composition and risk factors in a large cross-sectional IBS cohort
por: Agnello, Melissa, et al.
Publicado: (2020)

Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute
por: Carbone, Florencia, et al.
Publicado: (2022)

Development of a new version of the Bristol Stool Form Scale: translation, content validity, face validity, and reliability of the Persian version
por: Shokouhi, Nasim, et al.
Publicado: (2022)

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)
por: Howell, Carol Angela, et al.
Publicado: (2022)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Irritant-induced Asthma Caused by Aerotoxic Syndrome
por: Roig, Jorge, et al.
Publicado: (2021)

Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI
por: Murray, Kathryn, et al.
Publicado: (2014)

Host adaptation in gut Firmicutes is associated with sporulation loss and altered transmission cycle
por: Browne, Hilary P., et al.
Publicado: (2021)

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource
por: Stournaras, Evangelos, et al.
Publicado: (2021)

Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis
por: Altobelli, Emma, et al.
Publicado: (2017)

Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation
por: Browne, Hilary P., et al.
Publicado: (2016)

Is low FODMAP diet effective in children with irritable bowel syndrome?
por: Dogan, Guzide, et al.
Publicado: (2020)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
por: Harvie, Ruth M, et al.
Publicado: (2017)

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
por: Nanayakkara, Wathsala S, et al.
Publicado: (2016)

Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis
por: van Lanen, Anne-Sophie, et al.
Publicado: (2021)

Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care
por: Williams, Marianne, et al.
Publicado: (2016)

Correction to: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis
por: van Lanen, Anne-Sophie, et al.
Publicado: (2021)

Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses
por: Joachims, Michelle L, et al.
Publicado: (2022)

Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome
por: Wong, Zhiqin, et al.
Publicado: (2018)

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2020)

The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping
por: Beresford-Jones, Benjamin S., et al.
Publicado: (2022)

Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
por: Diarra, Ava, et al.
Publicado: (2021)

Effects of Sourdough on FODMAPs in Bread and Potential Outcomes on Irritable Bowel Syndrome Patients and Healthy Subjects
por: Menezes, Leidiane A. A., et al.
Publicado: (2018)

Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management
por: Rastgoo, Samira, et al.
Publicado: (2021)

A blood-based prognostic biomarker in IBD
por: Biasci, Daniele, et al.
Publicado: (2019)

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy
por: Bezzina, Oriana M., et al.
Publicado: (2017)

Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
por: Pirkola, Laura, et al.
Publicado: (2018)

Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?
por: Chumpitazi, Bruno P., et al.
Publicado: (2019)

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
por: Xie, Chao-Rong, et al.
Publicado: (2022)

The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
por: Chojnacki, Cezary, et al.
Publicado: (2023)

Strain-level characterization of broad host range mobile genetic elements transferring antibiotic resistance from the human microbiome
por: Forster, Samuel C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qjl2dv85dcbbcb2tncigr8nn6o